## BACKGROUND. The incidence and mortality of prostate cancer are increasing at alarming rates, partially due to an aging population. Early detection of prostate cancer, using clinically sensitive procedures and/or tumor markers (e.g., prostate-specific antigen [PSA]), is of prime importance. Howe
Prostate cancer and markers of bone metabolism: diagnostic, prognostic, and therapeutic implications
β Scribed by Eric C. Nelson; Christopher P. Evans; Chong-Xian Pan; Primo N. Lara
- Publisher
- Springer-Verlag
- Year
- 2007
- Tongue
- English
- Weight
- 264 KB
- Volume
- 25
- Category
- Article
- ISSN
- 0724-4983
No coin nor oath required. For personal study only.
π SIMILAR VOLUMES
## Abstract Our aim was to assess the diagnostic accuracy of bone markers in serum of patients with prostate cancer (PCa) for early detection of bone metastases and their usefulness as predictors of PCaβcaused mortality. In sera of 117 PCa patients (pN0M0, __n__ = 39; pN1M0, __n__ = 34; M1, __n__ =
## Abstract This study aimed to investigate the microRNA (miRNA) profile in prostate carcinoma tissue by microarray analysis and RTβqPCR, to clarify associations of miRNA expression with clinicopathologic data and to evaluate the potential of miRNAs as diagnostic and prognostic markers. Matched tum
## Abstract Nanotechnology is multidisciplinary field that involves the design and engineering of objects <500 nanometers (nm) in size. The National Cancer Institute has recognized that nanotechnology offers an extraordinary, paradigmβchanging opportunity to make significant advances in cancer diag